/

Investors / United States / Tellus BioVentures

Tellus BioVentures

Venture capital · Miromar Lakes, FL, United States · North America

tellusbv.com

Tellus BioVentures is a biotechnology investment fund focused on early-stage innovation and company formation. It makes seed-stage investments in private biotech ventures as lead or sole investor, participates in Series A rounds, and launches and funds de novo companies.

Invests inHealthcare & Biotech

In its own wordsbiotechlife sciencestherapeuticscompany formationearly stagehealthcare

Your fit with Tellus BioVentures

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
7portfolio companies
0funding rounds on record
Seed to Series Astages it states

Tellus BioVentures lists 7 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside Agent Capital, 5AM Ventures and BioAdvance.

No funding round on record names Tellus BioVentures yet, so the figures come from its portfolio page.

Investor profile

percentile among all firms
Portfolio size: 7 companiesRecent activity: 0 rounds in 12 monthsEarly stage: 0% of entries at pre-seed or seedEvidence: 0% of companies confirmed by a roundSector focus: 100% in its largest sectorReach: 1 countryPortfolio size12th pctRecent activity46th pctEarly stage54th pctEvidence52th pctSector focus100th pctReach20th pct
This firmMedian of all firms
Show as a table
Tellus BioVentures compared with all firms
MeasurePercentile of all firmsValue
Portfolio size12th7 companies
Recent activity46th0 rounds in 12 months
Early stage54th0% of entries at pre-seed or seed
Evidence52th0% of companies confirmed by a round
Sector focus100th100% in its largest sector
Reach20th1 country

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers686%
  • No longer answers00%
  • Points to another company114%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech100%15%

Co-investor network

who it backs companies with, and who they back together
5 shared companies4 shared companies4 shared companies4 shared companies3 shared companies3 shared companies3 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companiesAgent Capital: 3 shared companiesAgent Capital35AM Ventures: 1 shared companies5AM Ventures1BioAdvance: 1 shared companiesBioAdvance1BrightEdge: 1 shared companiesBrightEdge1Catalio Capital Management: 1 shared companiesCatalio Capital Manag…1DEFTA Partners: 1 shared companiesDEFTA Partners1DeepWork Capital: 1 shared companiesDeepWork Capital1Delos Capital: 1 shared companiesDelos Capital1Global BioAccess Fund: 1 shared companiesGlobal BioAccess Fund1Hatch Biofund: 1 shared companiesHatch Biofund1Longitude Capital: 1 shared companiesLongitude Capital1NEA: 1 shared companiesNEA1
Shared portfolio companies with Tellus BioVenturesFirms that also back companies together

All co-investors or Compare portfolios with Agent Capital

Compare Tellus BioVentures head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Portfolio

7 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
Aegle Therapeuticsaegletherapeutics.com · United StatesAegle Therapeutics is a pioneer in regenerative medicine developing extracellular vesicle (EV) therapy to meaningfully improve the lives of those suffering from debilitating rare diseases
Healthcare & Biotech
Portfolio page
Dianthusdianthustx.com · United StatesDianthus Therapeutics is developing potentially best in class therapies for patients living with severe autoimmune diseases.
Healthcare & Biotech
Portfolio page
Interius Biotherapeuticsinteriusbio.com · United States
Healthcare & Biotech
Portfolio page
Navrogennavrogen.com · United StatesNavrogen is developing therapeutic agents to overcome immunosuppressive effects of factors that suppress humoral immune responses produced by tumors
Healthcare & Biotech
Portfolio page
Praeventixpraeventix.comPraeventix is a clinical stage biopharmaceutical company committed to the discovery, research and clinical development of novel serotonergic therapeutics
Healthcare & Biotech
Portfolio page
Vittoria Biotherapeuticsvittoriabio.com · United StatesVittoria Biotherapeutics is a clinical-stage company that develops immunotherapies to address unmet clinical needs in oncology and immunology
Healthcare & Biotech
Portfolio page
Zenas Biopharmazenasbio.com · United StatesThe company develops therapies for autoimmune diseases.
Healthcare & Biotech
Portfolio page

About this data

site last read 7 Nov 2026
The homepage of Tellus BioVentures, as last read
tellusbv.com as VCinfo last read it
Site
tellusbv.com
Last read
7 Nov 2026
Watching since
7 Nov 2026
Companies checked
7

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get Tellus BioVentures' profile as data

Pull Tellus BioVentures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/tellusbv.com

# also
GET /v1/firms/tellusbv.com/portfolio
GET /v1/firms/tellusbv.com/coinvestors
GET /v1/firms/tellusbv.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing